Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ecolab
ECL
$79.5B
| $265M | 0.17% |
1,337,952
-96,479
| -7% | -$19.3M |
|
102
NVIDIA
NVDA
$5.3T
| $263M | 0.16% |
60,341,240
-13,393,360
| -18% | -$56.3M |
|
103
CALL
Tesla
TSLA
$1.26T
| $255M | 0.16% |
15,897,000
-3,793,590
| -19% | -$59.4M |
|
104
Gilead Sciences
GILD
$162B
| $244M | 0.15% |
3,845,167
+1,062,999
| +38% | +$69.5M |
|
105
NextEra Energy
NEE
$176B
| $243M | 0.15% |
4,176,840
+1,006,512
| +32% | +$54.5M |
|
106
Intuit
INTU
$88.1B
| $238M | 0.15% |
895,297
+11,478
| +1% | +$3.16M |
|
107
International Paper
IP
$21.5B
| $235M | 0.15% |
5,927,215
+3,703,313
| +167% | +$145M |
|
|
VMW
108
DELISTED
VMware, Inc
VMW
| $231M | 0.14% |
1,540,674
+493,268
| +47% | +$77.6M |
|
109
Altria Group
MO
$113B
| $231M | 0.14% |
5,652,544
+282,595
| +5% | +$13M |
|
110
Danaher
DHR
$141B
| $231M | 0.14% |
1,803,711
-13,905
| -0.8% | -$1.74M |
|
111
CALL
Visa
V
$692B
| $230M | 0.14% |
1,336,000
+407,800
| +44% | +$72.6M |
|
|
112
PUT
Alphabet (Google) Class A
GOOGL
$4.38T
| $229M | 0.14% |
3,756,000
-1,622,000
| -30% | -$96.1M |
|
113
Costco
COST
$421B
| $228M | 0.14% |
790,229
-80,946
| -9% | -$22.8M |
|
114
CVS Health
CVS
$123B
| $226M | 0.14% |
3,575,820
-840,194
| -19% | -$49.8M |
|
115
Salesforce
CRM
$153B
| $224M | 0.14% |
1,510,271
+89,324
| +6% | +$13.6M |
|
116
Walmart Inc
WMT
$892B
| $222M | 0.14% |
5,605,962
-5,084,991
| -48% | -$192M |
|
117
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $222M | 0.14% |
2,907,838
+386,747
| +15% | +$32.1M |
|
118
American Tower
AMT
$79.8B
| $219M | 0.14% |
990,661
-200,681
| -17% | -$43.8M |
|
119
Goldman Sachs
GS
$301B
| $217M | 0.14% |
1,047,086
+190,400
| +22% | +$39.8M |
|
|
120
PUT
Goldman Sachs
GS
$301B
| $214M | 0.13% |
1,033,000
+107,700
| +12% | +$22.5M |
|
121
iShares Core US Aggregate Bond ETF
AGG
$137B
| $207M | 0.13% |
1,831,031
+442,552
| +32% | +$49.8M |
|
122
iShares MBS ETF
MBB
$39B
| $200M | 0.12% |
1,842,851
-322,724
| -15% | -$34.8M |
|
123
McDonald's
MCD
$196B
| $199M | 0.12% |
927,310
-513,976
| -36% | -$110M |
|
124
PayPal
PYPL
$51.1B
| $198M | 0.12% |
1,909,723
-267,753
| -12% | -$29.5M |
|
125
3M
MMM
$93.2B
| $194M | 0.12% |
1,414,849
-235,569
| -14% | -$32.9M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.